written by Allyson Berent, DVM DACVIM When we refer to gene therapy in Angelman Syndrome (AS), we are typically referring […]
The Foundation for Angelman Syndrome Therapeutics (FAST) has funded two research labs at the University of California, Davis (UC Davis) […]
F. Hoffmann-La Roche Ltd, (Roche), one of the world’s largest pharmaceutical and diagnostics companies, announced today that it has funded […]
By Allyson Berent, DVM, DACVIM Recently published work from Dr. Edwin Weeber’s lab, funded by the Foundation for Angelman Syndrome […]
